Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg
USPTO PatentsView assignee record - 10 granted patents across 12 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).
The verdict
According to USPTO PatentsView, Arzneimittel ranks #25,787 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 12 technology areas.
- #25,787
- of 49,997 US assignees by volume
- 37th percentile
- by Innovation Score (31.2/100)
- 17.8
- avg claims per patent
- -89%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R25787 · Foreign Corporation #25,787 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL
- GRANTS-MICRO 10 grants
- MID-PACK #25,787/49,997
- PHOTO-FINISH Arista Cereal PTY
- CPC-FOCUS A61M · 12 areas
- INNOV-THIN 31.2/100
- CLAIMS-RICH 17.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-DROP -89% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Arista Cereal Technologies PTY Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Arzneimittel’s 31.2 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Arzneimittel
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Arzneimittel… · this assignee 31
Arzneimittel… · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Arzneimittel's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Arzneimittel?
Each dot is one of Arzneimittel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Arzneimittel’s own 17.8 claims/patent is ABOVE the 11.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Arzneimittel's grants concentrate
Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg is a focused PatentsView assignee: 12 CPC subclasses with 70% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2016. By volume, Arzneimittel sits between Arista Cereal Technologies PTY Limited and Asymchem Laboratories (FUXIN) Co., Ltd..
Who files at Arzneimittel's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Arista Cereal PTY
Arista Cereal Technologies PTY Limited
10 patents
- ARK Crystal
ARK Crystal, LLC
10 patents
- Arrow Acquisition
Arrow Acquisition, LLC
10 patents
- Artic Investments
Artic Investments S.A.
10 patents
- AS Strömungstechn…
AS Strömungstechnik GmbH
10 patents
- Ascendis Pharma E…
Ascendis Pharma Endocrinology Division A/S
10 patents
- Ascendo Medienage…
Ascendo Medienagentur AG
10 patents
- Asymchem Laborato…
Asymchem Laboratories (FUXIN) Co., Ltd.
10 patents
- Arzneimittel Apot… ◀
Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg
10 patents
What this shows Arzneimittel holds 10 patents at rank #25,711, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Arzneimittel
By rank, the assignees closest to #25,711 in granted patent volume.
- Arista Cereal Technologies PTY Limited #25,707 · 10 patents
- ARK Crystal, LLC #25,708 · 10 patents
- Arrow Acquisition, LLC #25,709 · 10 patents
- Artic Investments S.A. #25,710 · 10 patents
- AS Strömungstechnik GmbH #25,712 · 10 patents
- Ascendis Pharma Endocrinology Division A/S #25,713 · 10 patents
- Ascendo Medienagentur AG #25,714 · 10 patents
- Asymchem Laboratories (FUXIN) Co., Ltd. #25,715 · 10 patents
Leaders in A61M (Devices FOR Introducing Media Into)
Other assignees with the most granted patents in Arzneimittel's primary technology class.
- Becton, Dickinson and Company 1,249 in class
- Sanofi-Aventis Deutschland GMBH 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.V. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien LP 726 in class
- Terumo Kabushiki Kaisha 724 in class
- ResMed Pty Ltd 682 in class
Arzneimittel's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 37th percentile higher than 37% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2016 | 1 | 10.0% |
| 2017 | 3 | 30.0% |
| 2019 | 3 | 30.0% |
| 2021 | 1 | 10.0% |
Which technologies does Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg's patent record in context - here's where to go next.
- Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 70% of its portfolio - see every assignee active in that class. Explore A61M
- Ranked #25,787 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Arzneimittel GMBH Apotheker Vetter & Co. Ravensburg against Arista Cereal Technologies PTY Limited, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.